Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 13;10(11):1744. doi: 10.3390/nu10111744

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Competing risk model for association between protein intake and the study endpoints. Cumulative incidences (95% confidence interval) of (A) mortality and (B) end-stage renal disease (ESRD) in the very low protein intake (VLPI), low protein intake (LPI), and moderate protein intake (MPI) groups were 0.199 (0.099 to 0.324), 0.170 (0.107 to 0.246), and 0.060 (0.018 to 0.138), respectively, and 0.801 (0.513 to 0.929), 0.695 (0.519 to 0.818), and 0.781 (0.259 to 0.956), respectively. Thirty-one patients were excluded because of death (n = 6) or development of ESRD (n = 25) within the first 6 months of follow-up. ESRD was defined as hemodialysis, peritoneal dialysis, or kidney transplantation. Multivariable models included age, sex, BMI, CKD stage, and comorbidities (DM, CVD, and anemia) (Model 1).

Competing risk model for association between protein intake and the study endpoints. Cumulative incidences (95% confidence interval) of (A) mortality and (B) end-stage renal disease (ESRD) in the very low protein intake (VLPI), low protein intake (LPI), and moderate protein intake (MPI) groups were 0.199 (0.099 to 0.324), 0.170 (0.107 to 0.246), and 0.060 (0.018 to 0.138), respectively, and 0.801 (0.513 to 0.929), 0.695 (0.519 to 0.818), and 0.781 (0.259 to 0.956), respectively. Thirty-one patients were excluded because of death (n = 6) or development of ESRD (n = 25) within the first 6 months of follow-up. ESRD was defined as hemodialysis, peritoneal dialysis, or kidney transplantation. Multivariable models included age, sex, BMI, CKD stage, and comorbidities (DM, CVD, and anemia) (Model 1).